Table 4 Multivariate Cox regression analysis including c-Fos expression, residual tumour, FIGO stage, histologic subtype, and preoperative CA-125 serum levels to determine the impact on progression-free survival (A) and overall survival (B)

From: C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma

 

Progression-free survival

A

HR

95% CI

P -value

c-Fos

0.554

0.353–0.870

0.010

Residual tumour

4.824

1.226–18.990

0.024

FIGO stage

1.917

1.013–3.628

0.046

Histology

1.032

0.548–1.942

0.922

CA-125

1.936

0.888–4.222

0.097

 

Overall survival

B

HR

95% CI

P -value

c-Fos

0.546

0.310–0.961

0.036

Residual tumour

6.022

1.697–21.369

0.005

FIGO stage

1.390

0.589–3.277

0.452

Histology

1.048

0.493–2.228

0.903

CA-125

1.589

0.637–3.967

0.321

  1. CI=confidence interval; FIGO=International Federation of Gynecology and Obstetrics; HR=hazard ratio.
Back to article page